Abstract

Perivascular progenitor cells are of growing interest in the field of bone tissue engineering. Perivascular progenitor cells have mesenchymal stem/stromal cell (MSC) characteristics, including multipotentiality, self-renewal, immunomodulatory functions, and diverse roles in tissue repair. From human tissue, the purification of perivascular progenitor cells is most common from subcutaneous white adipose tissue, although all vascularized organs studied to date have a perivascular progenitor cell population. Microvascular pericytes are commonly isolated as a CD146+CD34−CD31−CD45− cell population, while adventitial progenitor cells are more commonly identified as a CD146−CD34+CD31−CD45− population. Perivascular progenitor cells have been applied in diverse orthopedic conditions, including both ectopic and orthotopic models of bone formation/regeneration. This review covers studies to date in bone tissue engineering as well as several emerging areas of study, including the concept of regional specification within the perivascular niche.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.